Mirae Asset Global ETFs Holdings’s Cogent Biosciences COGT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.37M	Buy	87,013 +11,043	+15%	+$386K	﹤0.01%	1016
2026 Q1	$2.9M	Buy	75,970 +4,886	+7%	+$180K	﹤0.01%	1022
2025 Q4	$2.54M	Buy	71,084 +3,084	+5%	+$86.7K	﹤0.01%	1047
2025 Q3	$975K	Buy	68,000 +5,358	+9%	+$63.5K	﹤0.01%	1506
2025 Q2	$449K	Buy	62,642 +367	+0.6%	+$2.04K	﹤0.01%	1869
2025 Q1	$377K	Buy	62,275 +3,693	+6%	+$29K	﹤0.01%	2018
2024 Q4	$456K	Buy	58,582 +3,831	+7%	+$38.2K	﹤0.01%	1964
2024 Q3	$592K	Buy	54,751 +5,523	+11%	+$53.8K	﹤0.01%	1835
2024 Q2	$415K	Buy	+49,228	New	+$373K	﹤0.01%	1909

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's COGT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Cogent Biosciences (COGT) stake by 15% in Q2 2026, buying an estimated $386K and bringing the position to 87,013 shares worth $3.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Mirae Asset Global ETFs Holdings first reported a position in COGT in Q2 2024 and has held it in 9 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Mirae Asset Global ETFs Holdings held 87,013 shares of Cogent Biosciences worth $3.37M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 11,043 Cogent Biosciences shares in Q2 2026, an estimated $386K.
Cogent Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1016 holding.
Mirae Asset Global ETFs Holdings first reported a position in Cogent Biosciences in Q2 2024 and has held it in 9 quarters since.
322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.